MedWatch

Novo has Danish life science's best reputation - Coloplast, Genmab and Widex are next

Novo Nordisk outpaces all other Danish life science companies, according to a new image report. The drug group only ranks low on one parameter.

Foto: Peter Nørby

Danes in- and outside the pharmaceutical industry have no doubts that Novo Nordisk is an admirable company.

In a new survey from MedWatch and analyst firm Wilke, Novo Nordisk ranks highest on 7 out of 8 parameters evaluating Denmark's 26 largest and most influential life science companies. Novo outperforms the competitors in several ways.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier